PP9 COMORBIDITY OF PATIENTS WITH NON-SMALL CELL LUNG CANCER AT DR. M. DJAMIL HOSPITAL PADANG

Dandy Irawan¹, Sabrina Ermayanti¹, Dewi Wahyu Fitrina²

¹Departement of Pulmonology and Respiratory Medicine, Faculty of Medicine Andalas University, Padang, West Sumatera, Indonesia
²Departement of Pulmonology and Respiratory Medicine, Dr. M. Djamil General Hospital, Padang, West Sumatera, Indonesia

Introduction
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. The severity of NSCLC is influenced not only by cancer staging but also by the presence of comorbidities. Patients with comorbidities are predominantly found in older age groups.

Objective
This study aimed to identify the comorbidities present in NSCLC patients treated at Dr. M. Djamil Hospital Padang.

Methodology
This was a descriptive study involving NSCLC patients treated at Dr. M. Djamil Hospital Padang from January 1, 2020 to December 31, 2022.

Result
A total of 122 NSCLC patients were diagnosed during the study period, with 30.3% having comorbidities. Male patients predominated in both groups, with and without comorbidities (89.2% vs 75.3%). The highest prevalence of patients with comorbidities was observed in the 60-69 age group (40.6%), whereas those without comorbidities were most common in the 50-59 age group (38.9%). Adenocarcinoma was the most frequent histological type in both groups (51.4% vs 45.9%; respectively). Chronic obstructive pulmonary disease (COPD) was the most common comorbidity, present in 32.4% of cases. Diagnostic delays occurred more frequently in patients with comorbidities than in those without (46% vs 35.3%). Furthermore, 67.6% of patients with comorbidities had only one comorbid condition.

Conclusion
NSCLC patients with comorbidities were more likely to be older and to experience diagnostic delays compared to those without comorbidities. COPD was the most frequently observed comorbidity and the majority of patients had a single comorbid condition.

Keyword: NSCLC, comorbidity, COPD